MedPath

Impact of quality of life to overall productivity impairment and activity impairment of patients with systemic lupus erythematosus

Not Applicable
Conditions
Systemic lupus erythematosus
-
Registration Number
JPRN-jRCT1030210647
Lead Sponsor
Tashiro Naoki
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
207
Inclusion Criteria

1. Patients with informed consent
2. Patients with Age >= 18 years old
3. Patients diagnosed with SLE >= 16 years old
4. Patients diagnosed as systemic lupus erythematosus according to the revised 1997 American College of Rheumatology (ACR) or SLICC criteria.

Exclusion Criteria

1. Patients with a diagnosis of SLE within 12 months.
2. Patients who are judged to need hospitalization when unscheduled visit.
3. Patient who, in the opinion of the investigator, is unlikely to comply with the protocol or is unsuitable for any other reason.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assess the residual burden remaining after meet LLDAS.
Secondary Outcome Measures
NameTimeMethod
Relationship between Activity Impairment and PROs in 2 groups (non LLDAS/LLDAS).
© Copyright 2025. All Rights Reserved by MedPath